Skip to content
★ Sign in to follow
EA

Eric A. Rose MD

Board Director
Director
Total declarations
87
Companies
5
▲ Purchases (5 ops.)
€70k
▼ Sales (21 ops.)
€5.4M

Latest filing published 21 Jun 2024 for Orchestra BioMed Holdings, Inc..

Filing timeline

BuySale
Eric A. Rose MD

Insider track record

Disclosed buys
5
Disclosed sells
21
Signal history

Closed purchases

Market purchases
5
Positive at T+90
100%
Median T+90
+18.8%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 15 Dec 2009 · 6172 days ago · €12k
    +120.5%
    Entry US$6.06 · Close at T+365 US$13.36
  • Filed 17 Dec 2008 · 6535 days ago · €21k
    +88.3%
    Entry US$3.26 · Close at T+365 US$6.14

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Eric A. Rose MD: trading record in brief

Eric A. Rose MD is a declared insider at 5 companies (board member); the most frequent names are Siga Technologies Inc, Abiomed Inc and Nephros Inc. Over a trading history stretching from 14 March 2006 to 20 June 2024, the count stands at 87 filings.

Both buying and selling appear: 5 purchases worth €70k, against 21 sales worth €5.4M. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 30 share grants and 31 option exercises.

Half of the purchases are above €19k and half below. After 3 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +18.8%. This is a record of the past, not a forecast.

The newest entry dates from 21 June 2024: a share grant, in Orchestra BioMed Holdings, Inc. The last insider purchase was made public on 7 January 2014, 4,688 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Eric A. Rose MD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations86 total
  • ◆
    DirectorExecutivesOrchestra BioMed Holdings, Inc.
    0SEC
    5,376 shares0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-24-074011:0
  • ◆
    DirectorExecutivesOrchestra BioMed Holdings, Inc.
    2,518 USD16SEC
    157 shares@ US$16.0450.1% of flowCommon StockSEC:0001213900-23-041642:1
  • ◇
    DirectorExecutivesOrchestra BioMed Holdings, Inc.
    2,511 USD19SEC
    2,325 shares@ US$1.08100.0% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001213900-23-041642:0
  • ◆
    DirectorExecutivesAbiomed Inc
    91,815 USD11SEC
    313 shares@ US$293.341.9% of flowCommon Stock, $.01 par valueSEC:0001415889-22-008527:1
  • ◆
    DirectorExecutivesAbiomed Inc
    0SEC
    681 shares0Common Stock, $.01 par valueSEC:0001415889-22-008527:0
  • ◆
    DirectorExecutivesAbiomed Inc
    84,768 USD11SEC
    265 shares@ US$319.881.5% of flowCommon Stock, $.01 par valueSEC:0001179110-21-008177:1
  • ◆
    DirectorExecutivesAbiomed Inc
    0SEC
    625 shares0Common Stock, $.01 par valueSEC:0001179110-21-008177:0
  • ◇
    DirectorExecutivesSiga Technologies Inc
    0SEC
    15,000 sharesCommon Stock, par value $.0001 per shareSEC:0001209191-21-041495:0
  • ◆
    DirectorExecutivesAbiomed Inc
    0SEC
    661 shares0Common Stock, $.01 par valueSEC:0001179110-20-009048:0
  • ◆
    DirectorExecutivesAbiomed Inc
    132,922 USD19SEC
    422 shares@ US$314.98100.0% of flowCommon Stock, $.01 par valueSEC:0001179110-20-008875:0
  • ◇
    DirectorExecutivesSiga Technologies Inc
    0SEC
    15,000 shares0Common Stock, Par Value $.0001 Per ShareSEC:0001140361-20-012329:0
  • ◇
    DirectorExecutivesSiga Technologies Inc
    0SEC
    100,000 shares0Common Stock, par value $.0001 per shareSEC:0001140361-19-021546:0
  • ◆
    DirectorExecutivesSiga Technologies Inc
    268,145 USD12SEC
    54,501 shares@ US$4.927.5% of flowCommon Stock, par value $.0001 per shareSEC:0001140361-19-021546:1
  • ◆
    DirectorExecutivesAbiomed Inc
    0SEC
    1,053 shares0Common Stock, $.01 par valueSEC:0001179110-19-009345:0
  • ◆
    DirectorExecutivesSiga Technologies Inc
    587,723 USD13SEC
    105,896 shares@ US$5.5515.9% of flowCommon Stock, par value $.0001 per shareSEC:0001140361-18-043708:1
  • ◇
    DirectorExecutivesSiga Technologies Inc
    0SEC
    200,000 shares0Common Stock, par value $.0001 per shareSEC:0001140361-18-043708:0
  • ◇
    Executive ChairmanExecutivesSiga Technologies Inc
    996,000 USD24SEC
    400,000 shares@ US$2.4923.2% of flowCommon Stock, par value $.0001 per shareSEC:0001140361-18-036816:0
  • ◆
    Executive ChairmanExecutivesSiga Technologies Inc
    2M USD26SEC
    234,277 shares@ US$7.9843.5% of flowCommon Stock, par value $.0001 per shareSEC:0001140361-18-036816:1
  • ◆
    DirectorExecutivesAbiomed Inc
    0SEC
    531 shares0Common Stock, $.01 par valueSEC:0001179110-18-010525:0
  • ◇
    Executive ChairmanExecutivesSiga Technologies Inc
    345,181 USD23SEC
    97,785 shares@ US$3.537.4% of flowCommon Stock, par value $.0001 per shareSEC:0001140361-17-043229:0
  • ◆
    Executive ChairmanExecutivesSiga Technologies Inc
    221,024 USD22SEC
    49,446 shares@ US$4.474.7% of flowCommon Stock, par value $.0001 per shareSEC:0001140361-17-043229:1
  • ◇
    DirectorExecutivesAbiomed Inc
    7,532 USD11SEC
    982 shares@ US$7.670.1% of flowCommon Stock, $.01 par valueSEC:0001179110-17-011954:0
  • ▼
    DirectorExecutivesAbiomed Inc
    142,557 USD26SEC
    982 shares@ US$145.172.6% of flowCommon Stock, $.01 par valueSEC:0001179110-17-011954:1
  • ◇
    DirectorExecutivesAbiomed Inc
    223,560 USD11SEC
    12,000 shares@ US$18.634.1% of flowCommon Stock, $.01 par valueSEC:0001179110-17-011866:0
  • ◇
    DirectorExecutivesAbiomed Inc
    84,508 USD11SEC
    11,018 shares@ US$7.671.5% of flowCommon Stock, $.01 par valueSEC:0001179110-17-011866:1

25 of 86 declarations